Related Experiment Video
Updated: May 3, 2026
06:42
A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
16.3K
[Anti-inflammatory potential of melatonin]
Klinicheskaia Meditsina
|January 21, 2014
Summary
Epiphyseal melatonin exhibits anti-inflammatory properties through cellular and systemic mechanisms. It enhances non-steroidal anti-inflammatory drug activity while preventing their side effects.
Area of Science:
- Endocrinology
- Immunology
- Pharmacology
Context:
- Melatonin, a hormone produced by the pineal gland, plays a crucial role in regulating circadian rhythms and has demonstrated immunomodulatory and anti-inflammatory effects.
- Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used to manage pain and inflammation but are associated with significant gastrointestinal and cardiovascular side effects.
Purpose:
- To summarize the anti-inflammatory properties of epiphyseal melatonin.
- To elucidate the cellular and systemic mechanisms underlying melatonin's anti-inflammatory actions.
- To investigate the dual effects of melatonin in combination with NSAIDs, focusing on the enhancement of therapeutic efficacy and mitigation of adverse effects.
Summary:
- Epiphyseal melatonin possesses significant anti-inflammatory properties, acting through both cellular and systemic pathways.
- Melatonin interacts with NSAIDs, demonstrating a dual effect: it potentiates the specific anti-inflammatory activity of NSAIDs and concurrently prevents the occurrence of their characteristic side effects.
- The proposed mechanisms involve modulation of inflammatory mediators and cellular signaling pathways.
Impact:
- This research highlights the potential of melatonin as an adjunct therapy to NSAIDs, offering a novel strategy to improve treatment outcomes for inflammatory conditions.
- Understanding these interactions could lead to the development of safer and more effective anti-inflammatory regimens.
- Further investigation into melatonin-NSAID synergy may pave the way for new therapeutic approaches in managing chronic inflammatory diseases.
Related Concept Videos
01:19Management of Insomnia
785
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
981
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
01:23Sedatives and Hypnotics: Overview
2.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.3K